Advicenne
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
262 Rue Du Faubourg Saint Honoré, Paris,...Website
www.advicenne.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Advicenne
Advicenne is a specialty pharmaceutical company dedicated to developing pediatric-friendly therapeutics for the treatment of orphan renal diseases and neurology. With over a decade of experience, the company focuses on innovative treatments for rare renal diseases, particularly distal renal tubular acidosis (dRTA) and cystinuria. Their flagship product, Sibnayal, has received regulatory approval in Europe and the UK, showcasing their commitment to improving the quality of life for patients with limited therapeutic options. Headquartered in Paris and listed on Euronext Growth, Advicenne aims to address high unmet medical needs for both children and adults.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Advicenne your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Advicenne is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Advicenne
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Advicenne has new funding data
Earning: See what the market has to say on Advicenne recently announced quarterly report
Check if Advicenne has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Advicenne launches new products
Click to see if Advicenne had a recent Job posting/layoffs
Advicenne, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Advicenne is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Advicenne is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Advicenne.
Advicenne financials insights
Gather financial insights about Advicenne, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Unspecified
$17.2M
Stock Offering
$36.4M
Advicenne Tech Stack
A closer look at the technologies used by Advicenne
See more technologies
Most Recent Scoops
Earnings
Sales
New Hire
Executive Move
Left Company
Executive Move
As previously announced David Solomon, Chairman of the Board has left the Board of Directors.
New Hire
Executive Move
Left Company
Executive Move
Advicenne News & Media
Advicenne Announces the Approval of All Resolutions Supported by the Board of Directors ...
Regulatory News: The Combined General Meeting of shareholders of Advicenne (Euronext Growth Paris ALDVI - FR0013296746) (Paris:ALDVI), a specialty phaAvanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries
AMSTERDAM--(BUSINESS WIRE)-- #dRTA--Avanzanite's expanded collaboration with Advicenne now includes Ireland, Cyprus and Malta in addition to existing markets (DE, AT, CH, GR, LI).Advicenne announces the approval of all resolutions supported by the Board of Directors at ...
Regulatory News: The Combined General Meeting of shareholders of Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical coAdvicenne 2022 Universal Registration Document Made Available
PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746) (Paris:ALDVI), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, announces today that its 2022 Universal Registration Document has been filed with the French Autorité des Marchés Financiers (AMF). The Universal Registration Document includes the annual report, the group management report, the Bo
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Advicenne
Sign Up For FreeTo access detailed company insights
Advicenne is a specialty pharmaceutical company dedicated to developing pediatric-friendly therapeutics for the treatment of orphan renal diseases and neurology. With over a decade of experience, the company focuses on innovative treatments for rare renal diseases, particularly distal renal tubular acidosis (dRTA) and cystinuria. Their flagship pro... Read More
